atb fungus
Comparative evaluation of ATB Fungus 2 and Sensititre
ATB Fungus 2 y SensititreYeastOne son métodos comerciales para el estudio de la sensibilidad in vitro de levaduras a los antifúngicos La concordancia entre estos dos métodos fue evaluada con un total de 133 aislamientos de Candida (60 Candida albicans 18 Candida dubliniensis 29 Candida glabrata y 26 Candida krusei) |
Does ATB fungus 3 compare with CLSI BMD after 24 h incubation?
The results obtained with the ATB FUNGUS 3 (both visual and automated readings) were compared with those of CLSI BMD after 24 h incubation.
Should azole drug susceptibilities be assessed by ATB?
The major errors in azole drug susceptibilities by ATB automated readings is a concern in China that can result in misleading clinical antifungal drug selection and pseudo high rates of antifungal resistance. Therefore, the ATB visual reading is generally recommended.
Is ATB fungus 3 a good test for Microbiology in developing countries?
The widely used but problematic ATB FUNGUS 3 with ATB Expression Bacteriology Analyzer automated readings (bioMérieux, La Balme-les Grottes, France) in China and its misleading reported high MICs of Candida spp. to azoles, gave a very good show case to highlight the challenges faced by clinical microbiology labs in developing countries.
Do fungistatic azoles cause antifungal tolerance?
This feature, related to antifungal tolerance, is mostly observed with the fungistatic azoles which incompletely inhibit the growth of some Candida spp. likely due to the activation of the stress response pathways ( Delarze and Sanglard, 2015; Maubon and Morio, 2018 ).
Introduction
The number of invasive fungal infections (IFI) observed in the last decades has risen in line with the continually growing number of immunosuppressed patients (Brown et al., 2012). This has led to an increased use of systemic antifungal drugs recommended to treat these infections including echinocandins, polyenes, triazoles and flucytosine. In addi
Conventional AFST Methods
Current AFST methods determine the susceptibility of a given fungal strain (in a pure culture) to a given antifungal drug. All of these methods are phenotypic, evaluating growth inhibition at defined concentrations of the drug in liquid or solid media. Most of them are quantitative as they measure the minimal inhibitory concentration (MIC), that is
Innovative AFST Methods Already Developed Or Under Development
Tests Based on MALDI-TOF Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectrometry (MS) consists in analyzing proteins of a sample after ionization and laser irradiation. Ionized particles are separated according to their mass-to-charge (m/z) ratio and detected in a TOF analyzer, resulting in a mass spectrum in which each detected peak corresponds to a protein/peptide (mostly ribosomal or a component of the cell wall). In the microbiological field, the resulting spectrum displays a spec
Discussion: Are Innovative Methods Better?
Slow growth and the trailing effect are the main problems of current AFST methods that are dependent on growth inhibition evaluation (i.e. EUCAST and CLSI reference methods in liquid or solid media, commercially available methods such as Sensititre™, Vitek 2, ATB fungus, Neo-Sensitabs™, Etest® and Liofilchem®). Therefore, AFST may be significantly
Conclusion
All current and innovative methods described above have some advantages and limitations, and none is perfect. The ideal AFST method needs to be fast, ideally less than 8h, to give results in a single working shift, so that the treatment may be adapted during the day. In addition, it needs to be culture independent, quantitative, functional in mixed
Author Contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work, and approved it for publication. frontiersin.org
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. frontiersin.org
Publisher’S Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. frontiersin.org
Multicenter Evaluation of ATB Fungus: A Standardized Micromethod
Abstract. The micromethod for yeast susceptibility testing ATB Fungus |
Yeast infections
ATB® FUNGUS 2. Ref. 14201. 25 strips + media. Determination of the MICs of 4 major antifungal agents: flucytosine amphotericin B |
Medio selectivo C. auris API 20C AUX ATB fungus
17 июл. 2019 г. ATB fungus. Page 2. 7/17/2019. 2 http://www.ilexmedical.com/files/ETEST_RG.pdf. Lectura E-test Anfotericina B. Sensititre Yeast One™ https://www ... |
Validación del método comercial ATB FUNGUS 3 frente al método
Conclusiones: El ATB FUNGUS 3 es una técnica rápida |
Comparison of ATB FUNGUS 2 and VITEK-2 Antifungal
3 сент. 2010 г. 1) ATB FUNGUS 2: ATB FUNGUS 2는 amphotericin B flu- cytosine |
168602 MICOLOGêA 21-2
Las CMIs se determinaron empleando el método de microdilución ATB Fungus (bioMérieux Francia). Se adoptaron como puntos de corte para interpretar la |
каталог
ATB™ наборы. Сухие готовые питательные среды. MYCOPLASMA IST2. VITEK® 2. VIDAS АТВ FUNGUS 3. Определение чувствительности дрожжей к антимикотикам. 25 тестов ... |
Porównanie lekowra¿liwoœci szczepów C. glabrata C. tropicalis
https://www.termedia.pl/Journal/-3/pdf-931-1?filename=Porownanie.pdf |
ANTIFUNGAL SUSCEPTIBILITY TESTING METHOD FOR
5 июл. 2006 г. E-test Alamar Blue |
Antifungal susceptibility profile and local epidemiological cut-off
6 дней назад We recommend the Sensititre YeastOne as the best option for antifungal susceptibility testing for Y. lipolytica followed by the ATB FUNGUS 3. |
Evaluation of ATB Fungus 3 for Antifungal Susceptibility Testing of
The purpose of the present study was to evaluate the performance of ATB. Fungus 3 in comparison to the CLSI broth microdilution (BMD) method for testing the |
Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne
ATB Fungus 2 and SensititreYeastOne are commercial methods for antifungal susceptibility testing of yeasts. The agreement between these two methods. |
P1600 Abstract (poster session) Evaluation of ATB Fungus 3 for
Evaluation of ATB Fungus 3 for antifungal susceptibility testing of Candida spp. by visual and automatic result-reading against broth microdilution method. |
Redalyc.Comparison of the ATB ® Fungus 2 with the AFST-EUCAST
The commercial panel ATB® Fungus 2 was compared with the reference testing method of the European Subcommittee on Antifungal Susceptibility Testing of the |
Annales du Contrôle National de Qualité des Analyses de Biologie
laboratoires des CMI trouvées avec l'ATB Fungus 2 réactif le plus utilisé pour la détermination des CMI. Le pourcentage de réponses « sensible » |
Présentation PowerPoint
validées / méthodes de référence. % corrélation avec les standards (CLSI EUCAST) . ?Etest®. ?Sensititre YeastOne®. ?Vitek®2. ?ATB™ Fungus 3. |
168602 MICOLOGêA 21-2
albicans (67 out of 77 isolates) resistant to 5FC were serotype B isolates. 5-fluorocytosine Candida |
Validación del método comercial ATB FUNGUS 3 frente al método
Validation of the commercial method ATB FUNGUS 3 against the reference method M27-A2 to determine the susceptibility of Candida albicans to. |
Sensibilité in vitro aux antifongiques des souches de candida
La galerie ATB Fungus 3 comportes 16 paires de cupules. La première paire sans antifongique |
Comparison of ATB FUNGUS 2 and VITEK-2 Antifungal
3 sept. 2010 ATB FUNGUS 2 (bioMérieux) and VITEK-2 (AST-. YS01) systems to the CLSI M27 method for suscept- ibility testing of Candida isolates. |
Sensibilité in vitro aux antifongiques des souches de candida
La galerie ATB Fungus 3 comportes 16 paires de cupules La première paire, sans antifongique, sert de témoin de croissance Les 15 suivantes contiennent 5 |
10PAR1 - ANSM
Annales Parasitologie 10PAR1 17 / 26 Fluconazole 0,0 20,0 40,0 60,0 80,0 100,0 < 16 16 32 > 32 CMI (mg/l) Vitek 2 (n=319) ATB Fungus 3 (n=337) |
Prescription antifongique et émergence de la résistance - Infectiologie
ATB fungus® (Biomerieux) Micronaut® (Merlin) Sensititre YeastOne® (Trek Diagnostic Systems) Vitek 2 antifungal susceptibility system (Biomerieux) Souvent |
ANTIFONGIGRAMME
V 2 1 ATB-Fungus [53, 65,104] Cette technique permet de déterminer la sensibilité des Candida et des Cryptococcus neoformans aux antifongiques en milieu |
Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne
ATB Fungus 2 and SensititreYeastOne are commercial methods for antifungal susceptibility testing of yeasts The agreement between these two methods |
PROFIL DE RÉSISTANCE DE CANDIDA ALBICANS D - EDUCI
le kit ATB Fungus 3 Résultats : Sur les 105 souches collectées, la culture sur milieu chromogénique a permis d'identifier 68 espèces de Candida albicans (64, 8 |
RedalycComparison of the ATB ® Fungus 2 with the AFST-EUCAST
Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp Forma de citar: Montiel Ramos JE, Corrales Bernal A, |
In vitro susceptibilities to yeasts using the ATB w FUNGUS 2 method
10 juil 2007 · France) is a modification of the former ATB FUNGUS and adds fluconazole and itraconazole to 5-flucytosine and amphotericin B, which were |